PMID- 37919532 OWN - NLM STAT- MEDLINE DCOM- 20231130 LR - 20231217 IS - 1708-0428 (Electronic) IS - 0960-8923 (Linking) VI - 33 IP - 12 DP - 2023 Dec TI - Experience of Robotic Complex Revisional Bariatric Surgery in a High-Volume Center. PG - 4034-4041 LID - 10.1007/s11695-023-06916-5 [doi] AB - PURPOSE: A revisional bariatric surgery (RBS) is necessary in about 28% of the patients. The role of robotic surgery in RBS is still a subject of debate. We aim to report the outcomes of robotic-assisted RBS at our institution. MATERIALS AND METHODS: We identified patients who underwent robotic-assisted RBSs between January 1, 2016, and May 31, 2022. We analyzed patient demographics and indications for surgery. Measured outcomes included peri- and postoperative morbidity, comorbidity management, and weight loss outcomes. RESULTS: A total of 106 patients were included. Primary procedures were adjustable gastric band 44 (41.5%), sleeve gastrectomy 42 (39.6%), Roux-en-Y gastric bypass (RYGB) 18 (17%), duodenal switch (DS) 1 (0.9%), and vertical banded gastroplasty 1 (0.9%). RBSs performed included 85 (78.7%) RYGB, 16 (14.8%) redo-gastrojejunostomy, and 5 (4.6%) DS. The median time to revision was 8 (range 1-36) years, and the main indication was insufficient weight loss (49%). Median length of hospital stay was 2 (range 1-16) days, and 9 (8.5%) patients were readmitted during the first 30 days. Only 4 (3.7%) patients had early Clavien-Dindo grade III or higher adverse events. No anastomotic leaks were documented. Median excess weight loss was 35.1%, 42.23%, and 45.82% at the 6-, 12-, and 24-month follow-up. Of 57 patients with hypertension, 29 (50.9%) reduced their medication dosage, and 20/27 (74.1%) reduced their diabetes mellitus medication dosage. Finally, of the 75 patients with symptoms, 64 (85.3%) reported an improvement after the RBS. CONCLUSION: Robotic-assisted RBS is feasible, significantly improves patients' comorbidities and symptoms, and leads to considerable weight loss. CI - (c) 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Castillo-Larios, Rocio AU - Castillo-Larios R AUID- ORCID: 0000-0002-2147-9343 AD - Department of General Surgery, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. FAU - Cornejo, Jorge AU - Cornejo J AD - Department of General Surgery, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. FAU - Gunturu, Naga Swati AU - Gunturu NS AD - Department of General Surgery, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. FAU - Cheng, Yilon Lima AU - Cheng YL AD - Department of General Surgery, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. FAU - Elli, Enrique F AU - Elli EF AD - Department of General Surgery, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. Elli.enrique@mayo.edu. LA - eng PT - Journal Article DEP - 20231103 PL - United States TA - Obes Surg JT - Obesity surgery JID - 9106714 SB - IM MH - Humans MH - *Obesity, Morbid/surgery MH - *Robotic Surgical Procedures/methods MH - *Laparoscopy/methods MH - Retrospective Studies MH - *Gastric Bypass/adverse effects/methods MH - *Gastroplasty/methods MH - *Bariatric Surgery/methods MH - Weight Loss MH - Reoperation/methods OTO - NOTNLM OT - Duodenal Switch OT - Redo Gastro-jejunostomy OT - Robotic-assisted OT - Roux-en-Y Gastric Bypass OT - gastric band OT - revisional bariatric surgery EDAT- 2023/11/03 06:43 MHDA- 2023/11/30 06:44 CRDT- 2023/11/03 00:40 PHST- 2023/01/17 00:00 [received] PHST- 2023/10/18 00:00 [accepted] PHST- 2023/10/17 00:00 [revised] PHST- 2023/11/30 06:44 [medline] PHST- 2023/11/03 06:43 [pubmed] PHST- 2023/11/03 00:40 [entrez] AID - 10.1007/s11695-023-06916-5 [pii] AID - 10.1007/s11695-023-06916-5 [doi] PST - ppublish SO - Obes Surg. 2023 Dec;33(12):4034-4041. doi: 10.1007/s11695-023-06916-5. Epub 2023 Nov 3.